In a regulatory filing, Clover Health Investments disclosed that on December 22, the board of directors of the company appointed Terrence Ronan as Interim Chief Financial Officer, including as principal financial officer and principal accounting officer, effective as of January 27, 2024. In order to ensure a smooth transition of responsibilities, Ronan will join the company as Interim Senior Vice President of Finance effective as of January 2, 2024, and will serve in that role until becoming the Interim Chief Financial Officer on January 27, 2024, following Scott Leffler’s previously announced departure as Chief Financial Officer, the filing stated. Ronan has served as an independent contractor of AlixPartners since 2023 and Ronan’s services as Interim Chief Financial Officer will be provided pursuant to an arrangement with Alix Partners, the filing noted.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CLOV:
- Gen Z Stocks: The Path from Gambling to Investment
- Clover Health Announces Departure of Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for 2023
- Clover Health announces departure of CFO Leffler
- Clover Health to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
- Clover Health to exit CMS ACO REACH Program at end of 2023
